Cargando…
Comparison of Laboratory Data between Children with Kawasaki Disease and COVID-19
Background: Coronavirus disease 2019 (COVID-19) has been an emerging, rapidly evolving situation in China since late 2019 and has even become a worldwide pandemic. The first case of severe childhood novel coronavirus pneumonia in China was reported in March 2020 in Wuhan. The severity differs betwee...
Autores principales: | Liu, Xiao-Ping, Huang, Ying-Hsien, Tsai, Yuh-Chyn, Liu, Shih-Feng, Kuo, Ho-Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139634/ https://www.ncbi.nlm.nih.gov/pubmed/35626814 http://dx.doi.org/10.3390/children9050638 |
Ejemplares similares
-
Comparison of laboratory data between children with COVID‐19 and influenza
por: Liu, Xiao‐Ping, et al.
Publicado: (2021) -
Comparison of the Laboratory Data Between Kawasaki Disease and Enterovirus After Intravenous Immunoglobulin Treatment
por: Lin, Li-Yan, et al.
Publicado: (2012) -
A novel score system of blood tests for differentiating Kawasaki disease from febrile children
por: Tsai, Chih-Min, et al.
Publicado: (2021) -
Increase expression of CD177 in Kawasaki disease
por: Huang, Ying-Hsien, et al.
Publicado: (2019) -
IL13 Promoter (−1055) Polymorphism Associated with Leukocyte Mitochondria DNA Copy Number in Chronic Obstructive Pulmonary Disease
por: Liu, Shih-Feng, et al.
Publicado: (2022)